1. [3H]Digitoxin was incubated for 2-5 h with liver slices from control and phenobarbital-pretreated guinea-pigs. Metabolites were the same in both groups. 2. After 5 h incubation, a 6-fold increase in unmetabolized digitoxin was found in the phenobarbital-pretreated group compared with controls. 3. The major metabolite extracted by chloroform is formed by hydroxylation at an unknown position of the cardenolide nucleus, which is not the 12 beta-hydroxy position. Only half the amount of this metabolite was formed in livers of pretreated animals, compared to controls, in 2 h, after 5 h incubation similar amounts occurred in both groups. 4. Water-soluble metabolites decreased 2-fold in phenobarbital-pretreated animals at 2 and 5 h of incubation.
The influence of phenobarbital pretreatment on liver concentration of digitoxin and its metabolites was studied in guinea-pigs after i.p. administration of the cardiac glycoside. During the first hour an increase in liver uptake was observed in pretreated animals. The differences detected in the hepatic subcellular distribution do not seem to explain the higher concentrations found in the liver of phenobarbital pretreated animals. About 80% of the liver radioactivity was found in the supernatants. Inhibition of digitoxin biotransformation by phenobarbital was demonstrated by chromatographic analysis of the organic soluble compounds present in the supernatants. The possible binding of digitoxin and its metabolites to soluble proteins of liver cytosol was excluded by thin-layer gel filtration. The decrease in digitoxin biotransformation seems to be the reason for the increase in liver uptake and for the decrease in bile concentrations, observed in phenobarbital pretreated animals.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.